Parties d'ouvrages collectifs (3)
  1. 1. Kohlbrenner, A. M., Ledent, C., Deligne, C., & Parmentier, I. (2014). La gestion des eaux usées en Belgique et le sort de la Senne à Bruxelles depuis 1945. In Trajectoires villes-fleuves. Paris: Editions Quae.
  2. 2. Blum, D., Martire, A., Burnouf, S., Sablonnière, B., Krystkowiak, P., Ledent, C., Lopes, L. V., & Popoli, P. (2013). Adenosine receptors in Huntington's disease. In Adenosine: A Key Link between Metabolism and Brain Activity (pp. 409-434). Springer New York. doi:10.1007/978-1-4614-3903-5_20
  3. 3. Coppee, F., Ledent, C., Clément, S., Dessars, B., Goffard, J.-C., Parma, J., Parmentier, M., Schurmans, S., & Dumont, J. E. (1999). Transgenic models of thyroid tumorigenesis relation to Chernobyl cancers. In G. Thomas, A. Karaouglou, & E. D. Williams (Eds.), Radiation and Thyroid Cancer (pp. 239-249). Singapore 239-249: World Scient. Publ.
    4.   Articles dans des revues avec comité de lecture (260)
  4. 1. Van Heurck, R., Bonnefont, J., Wojno, M., Suzuki, I., Velez-Bravo, F. F., Erkol, E., Nguyen, D. T., Herpoel, A., Bilheu, A., Beckers, S., Ledent, C., & Vanderhaeghen, P. (2023). CROCCP2 acts as a human-specific modifier of cilia dynamics and mTOR signaling to promote expansion of cortical progenitors. Neuron, 111(1), 65-80.e6. doi:10.1016/j.neuron.2022.10.018
  5. 2. Agba, S. S., Hanif, A., Ledent, C., Stephen, T. T., & Nayeem, M. M. (2022). Inhibition or deletion of Adenosine A2A receptor enhances acetylcholine-induced vascular response: role of angiotensin-II in A2A AR-/- vs. C57Bl/6 mice. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 36. doi:10.1096/fasebj.2022.36.S1.L7712
  6. 3. C. Leal, E., Liane, L. L., Pirzgalska, R. R., Marques-da-Silva, D., Ledent, C., Köfalvi, A., & Carvalho, E. (2021). Diabetes and Cannabinoid CB1 receptor deficiency promotes similar early onset aging-like changes in the skin. Experimental gerontology, 154, 111528. doi:10.1016/j.exger.2021.111528
  7. 4. Hanif, A., Agba, S. S., Ledent, C., Tilley, S. S., Morisseau, C., & Nayeem, M. M. (2021). Adenosine A2A receptor and vascular response: role of soluble epoxide hydrolase, adenosine A1 receptor and angiotensin-II. Molecular and cellular biochemistry. doi:10.1007/s11010-021-04049-w
  8. 5. Echeazarra, L., García del Caño, G., Barrondo, S., González-Burguera, I., Saumell-Esnaola, M., Aretxabala, X., López de Jesús, M., Borrega-Román, L., Mato, S., Ledent, C., Matute, C., Goicolea, M. A., & Sallés, J. (2021). Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1. Histochemistry and cell biology. doi:10.1007/s00418-021-02025-5
  9. 6. Patel, M., Narke, D., Kurade, M., Frey, K. K., Rajalingam, S., Siddiquee, A., Mustafa, J. S., Ledent, C., & Ponnoth, D. D. (2020). Limonene-induced activation of A2A adenosine receptors reduces airway inflammation and reactivity in a mouse model of asthma. Purinergic Signalling. doi:10.1007/s11302-020-09697-z
  10. 7. Wilkerson, J. J., Alberti, L. L., Kerwin, A. A., Ledent, C., Thakur, G. G., Makriyannis, A., & Milligan, E. E. (2020). Peripheral versus central mechanisms of the cannabinoid type 2 receptor agonist AM1710 in a mouse model of neuropathic pain. Brain and Behavior. doi:10.1002/brb3.1850
  11. 8. González de San Román, E., Manuel, I., Ledent, C., Chun, J., Rodríguez de Fonseca, F., Estivill-Torrús, G., Santín, L. J., & Rodríguez-Puertas, R. (2019). CB1 and LPA1 Receptors Relationship in the Mouse Central Nervous System. Frontiers in Molecular Neuroscience, 12, 223. doi:10.3389/fnmol.2019.00223
  12. 9. Moura, L. L., Lemos, C., Ledent, C., Carvalho, E., & Köfalvi, A. (2019). Chronic insulinopenia/hyperglycemia decreases cannabinoid CB 1 receptor density and impairs glucose uptake in the mouse forebrain. Brain research bulletin, 147, 101-109. doi:10.1016/j.brainresbull.2019.01.024
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Suivant >>